4.7 Article

Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria

期刊

ANTIOXIDANTS & REDOX SIGNALING
卷 37, 期 10-12, 页码 739-757

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2019.8007

关键词

Alzheimer's disease; hypoxic preconditioning; mitochondria; hippocampus; streptozotocin

资金

  1. Portuguese national funds via FCT -Fundacao para a Ciencia e a Tecnologia [UIDB/04539/2020, UIDP/04539/2020, PEst-OE/SAU/UI0215/2019, UID/QUI/00062/2019]
  2. European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme (Projects Healthy Aging2020) by COMPETE 2020-Operational Programme for Competitiveness and Internationalisation
  3. [DL57/2016]
  4. [SFRH/BPD/109822/2015]

向作者/读者索取更多资源

This study demonstrates that hypoxic preconditioning can prevent the sAD-like phenotype, partly by targeting mitochondria as a preventive strategy in the context of AD. Preconditioning with hypoxia enhances complex II-energized mitochondrial respiration in the hippocampus, improving mitochondrial function and mitochondrial DNA content. These findings provide a novel direction for hypoxic preconditioning as a preventive strategy for AD.
Aims: Brief episodes of sublethal hypoxia reprogram brain response to face possible subsequent lethal stimuli by triggering adaptive and prosurvival events-a phenomenon denominated hypoxic preconditioning (HP). To date, the potential therapeutic implications of HP to forestall sporadic Alzheimer's disease (sAD) pathology remain unexplored. Using a well-established protocol of HP and focusing on hippocampus as a first brain region affected in AD, this study was undertaken to investigate the potential protective effects of HP in a sAD rat model induced by the intracerebroventricular (icv) administration of streptozotocin (STZ) and to uncover the mitochondrial adaptations underlying this nonpharmacological strategy.Results: HP prevented the memory and learning deficits as well as tau pathology in the icvSTZ rat model. HP also attenuated icvSTZ-related reactive astrogliosis, as noted by increased glial fibrillary acidic protein immunoreactivity and myo-inositol levels. Notably, HP abrogated the icvSTZ-related impaired energy metabolism and oxidative damage. Particularly, HP averted increased lactate, glutamate, and succinate levels, and decreased mitochondrial respiratory chain function and mitochondrial DNA content. Concerning mitochondrial adaptations underlying HP-triggered tolerance to icvSTZ, preconditioned hippocampal mitochondria displayed an enhanced complex II-energized mitochondrial respiration, which resulted from a coordinated interaction between mitochondrial biogenesis and fusion-fission. Mitochondrial biogenesis was stimulated immediately after HP, whereas in a latter phase mitochondrial fusion-fission events are modulated favoring the generation of elongated mitochondria.Innovation and Conclusion: Overall, these results demonstrate for the first time that HP prevents the sAD-like phenotype, in part, by targeting mitochondria emerging as a preventive strategy in the context of AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据